Drive Smarter Pharmacy Decisions with Peer-Led Clinical Support

How RxBenefits’ pharmacist-led
independent clinical management
helps improve outcomes

Hospital pharmacy leaders are no strangers to the pressures of rising costs, clinical complexity, and limited resources. With expensive specialty drugs and GLP-1s driving pharmacy spend – and operational capacity stretched thin – there’s a growing need for data, insights, and support to help relieve the burden

With independent clinical management that delivers actionable insights, expert peer review, and targeted interventions, RxBenefits can be a powerful extension of your team. Conducted by clinicians – not algorithms – and focused on the high-cost drug categories that have the greatest impact, it can help reduce inappropriate prescribing and ensure better outcomes.

Consider that*:

~2% of a plan’s prescription claims = ~50% of total pharmacy benefits plan costs*

~80% of new drugs are specialty medications**

~50% of new drugs exceed $150K annually**

*Based on RxBenefits Book of Business, 2024
**IQVIA Institute, The Use of Medicines in the U.S. 2022

Why How clinical management makes your pharmacy plan more efficient:

Ensures the plan is administered in line
with its goals

Enforces appropriate dosing and use based on FDA-approved
guidelines

Flags inappropriate
or potentially unsafe
prescriptions before
they’re filled

Traditional PBMs without independent clinical management use algorithms to make coverage decisions on high-cost brand and specialty drugs. As a result, inappropriate or off-label prescriptions may slip through, driving up costs and member risk.

What’s more, these decisions often occur without input from the people who know the pharmacy best: pharmacists.

recaptcha logo This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.